Correlation Between Sabre Corpo and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Sabre Corpo and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sabre Corpo and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sabre Corpo and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Sabre Corpo and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sabre Corpo with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sabre Corpo and Mineralys Therapeutics,.
Diversification Opportunities for Sabre Corpo and Mineralys Therapeutics,
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Sabre and Mineralys is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Sabre Corpo and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Sabre Corpo is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sabre Corpo are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Sabre Corpo i.e., Sabre Corpo and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Sabre Corpo and Mineralys Therapeutics,
Given the investment horizon of 90 days Sabre Corpo is expected to generate 0.6 times more return on investment than Mineralys Therapeutics,. However, Sabre Corpo is 1.66 times less risky than Mineralys Therapeutics,. It trades about 0.19 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.01 per unit of risk. If you would invest 362.00 in Sabre Corpo on September 13, 2024 and sell it today you would earn a total of 41.00 from holding Sabre Corpo or generate 11.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sabre Corpo vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Sabre Corpo |
| Mineralys Therapeutics, |
Sabre Corpo and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sabre Corpo and Mineralys Therapeutics,
The main advantage of trading using opposite Sabre Corpo and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sabre Corpo position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Sabre Corpo vs. Expedia Group | Sabre Corpo vs. Trip Group Ltd | Sabre Corpo vs. Booking Holdings | Sabre Corpo vs. Despegar Corp |
| Mineralys Therapeutics, vs. Puma Biotechnology | Mineralys Therapeutics, vs. Iovance Biotherapeutics | Mineralys Therapeutics, vs. Sarepta Therapeutics | Mineralys Therapeutics, vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |